Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of the American Chemical Society|May 4, 2026
In Crystallo Synthesis of a Triplet Silver NitrenePritam Roychowdhury, Aishanee Sur, Matthew T Figgins, et al.International Journal of Nanomedicine|October 22, 2019
CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in miceLaboni Mondal, Biswajit Mukherjee, Kaushik Das, et al.Blood|July 23, 2025
A BCMA-mRNA vaccine is a promising therapeutic for multiple myelomaDebasmita Dutta, Jiye Liu, Kenneth Wen, et al.ACS Applied Materials & Interfaces|August 23, 2021
Polymeric Composite Matrix with High Biobased Content as Pharmaceutically Relevant Molecular Encapsulation and Release PlatformRaj Shankar Hazra, Debasmita Dutta, Babak Mamnoon, et al.Pharmacology Research & Perspectives|March 21, 2021
CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progressionAmlan Das, Inamul Haque, Priyanka Ray, et al.Plos One|April 30, 2024
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse modelDebasmita Dutta, Priyanka Ray, Archana De, et al.Journal of Biomedical Science|August 20, 2024
EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironmentDebasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.Molecular Pharmaceutics|November 5, 2020
Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of DoxorubicinChowdhury S Abdullah, Priyanka Ray, Shafiul Alam, et al.Cancer Letters|February 19, 2024
CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancerDivya Murthy, Debasmita Dutta, Kuldeep S Attri, et al.Research Square|June 5, 2025
Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer CellsDebasmita Dutta, Sunil Upadhyay, Archana De, et al.Pageof 3